Literature DB >> 16304592

Progressive changes in diabetics and their management.

G W Aylward1.   

Abstract

The prevalence of diabetic retinopathy is increasing worldwide due to an increasing number, and prolonged survival, of diabetic patients. Many effective treatments for different types and stages of retinopathy exist. However, there is patchy delivery of care, inconsistent screening, and unresolved questions about several management questions. This article discusses the current state of knowledge about therapeutics in diabetic retinopathy, and highlights areas where further studies and evidence base is required.

Entities:  

Mesh:

Year:  2005        PMID: 16304592     DOI: 10.1038/sj.eye.6701969

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  14 in total

1.  Prevalence and risk factors of diabetic retinopathy in Chongqing pre-diabetes patients.

Authors:  X Chen; Y Zhao; Z Zhou; X Zhang; Q Li; L Bai; M Zhang
Journal:  Eye (Lond)       Date:  2012-03-23       Impact factor: 3.775

Review 2.  Mitochondrial dysfunction in retinal diseases.

Authors:  Megha Barot; Mitan R Gokulgandhi; Ashim K Mitra
Journal:  Curr Eye Res       Date:  2011-10-06       Impact factor: 2.424

Review 3.  Oxidative stress and diabetic retinopathy: development and treatment.

Authors:  G D Calderon; O H Juarez; G E Hernandez; S M Punzo; Z D De la Cruz
Journal:  Eye (Lond)       Date:  2017-04-28       Impact factor: 3.775

Review 4.  Emerging Theranostic Nanomaterials in Diabetes and Its Complications.

Authors:  Yuntao Liu; Siqi Zeng; Wei Ji; Huan Yao; Lin Lin; Haiying Cui; Hélder A Santos; Guoqing Pan
Journal:  Adv Sci (Weinh)       Date:  2021-11-25       Impact factor: 16.806

Review 5.  Microvascular complications and diabetic retinopathy: recent advances and future implications.

Authors:  Megha Barot; Mitan R Gokulgandhi; Sulabh Patel; Ashim K Mitra
Journal:  Future Med Chem       Date:  2013-03       Impact factor: 3.808

Review 6.  Diabetic macular edema: what is focal and what is diffuse?

Authors:  David J Browning; Michael M Altaweel; Neil M Bressler; Susan B Bressler; Ingrid U Scott
Journal:  Am J Ophthalmol       Date:  2008-09-05       Impact factor: 5.258

Review 7.  The stress response protein REDD1 as a causal factor for oxidative stress in diabetic retinopathy.

Authors:  William P Miller; Siddharth Sunilkumar; Michael D Dennis
Journal:  Free Radic Biol Med       Date:  2021-01-29       Impact factor: 7.376

8.  Anti-oxidant effect of gold nanoparticles restrains hyperglycemic conditions in diabetic mice.

Authors:  Selvaraj Barathmanikanth; Kalimuthu Kalishwaralal; Muthuirulappan Sriram; Sureshbabu Ram Kumar Pandian; Hyung-Seop Youn; Soohyun Eom; Sangiliyandi Gurunathan
Journal:  J Nanobiotechnology       Date:  2010-07-14       Impact factor: 10.435

9.  Levels of selected oxidative stress markers in the vitreous and serum of diabetic retinopathy patients.

Authors:  Vlatka Brzović-Šarić; Irena Landeka; Borna Šarić; Monika Barberić; Lidija Andrijašević; Branimir Cerovski; Nada Oršolić; Domagoj Đikić
Journal:  Mol Vis       Date:  2015-06-12       Impact factor: 2.367

Review 10.  Oxidative stress and diabetic retinopathy.

Authors:  Renu A Kowluru; Pooi-See Chan
Journal:  Exp Diabetes Res       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.